105 related articles for article (PubMed ID: 10189562)
1. Cardiovascular disease in diabetes, beyond glucose.
Eckel RH; Bornfeldt KE; Goldberg IJ
Cell Metab; 2021 Aug; 33(8):1519-1545. PubMed ID: 34289375
[TBL] [Abstract][Full Text] [Related]
2. The Relationship Between Diabetes Mellitus and Cancers and Its Underlying Mechanisms.
Zhu B; Qu S
Front Endocrinol (Lausanne); 2022; 13():800995. PubMed ID: 35222270
[TBL] [Abstract][Full Text] [Related]
3. The Relationship Between Glycemic Control and Concomitant Hypertension on Arterial Stiffness in Type II Diabetes.
Nuamchit T; Siriwittayawan D; Thitiwuthikiat P
Vasc Health Risk Manag; 2020; 16():343-352. PubMed ID: 32943869
[TBL] [Abstract][Full Text] [Related]
4. Influence of Diabetes on Trends in Perioperative Cardiovascular Events.
Newman JD; Wilcox T; Smilowitz NR; Berger JS
Diabetes Care; 2018 Jun; 41(6):1268-1274. PubMed ID: 29618572
[TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus is a coronary heart disease risk equivalent for peripheral vascular disease.
Newman JD; Rockman CB; Kosiborod M; Guo Y; Zhong H; Weintraub HS; Schwartzbard AZ; Adelman MA; Berger JS
Am Heart J; 2017 Feb; 184():114-120. PubMed ID: 28224925
[TBL] [Abstract][Full Text] [Related]
6. Influence of risk factors and comorbidities on the successful therapy and survival of patients with critical limb ischemia.
Constantinescu MI; Constantinescu DP; Chiş B; Andercou A; Mironiuc IA
Clujul Med; 2013; 86(1):57-64. PubMed ID: 26527918
[TBL] [Abstract][Full Text] [Related]
7. Diabetes care and outcomes for American Indians and Alaska natives in commercial integrated delivery systems: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) Study.
Schmittdiel JA; Steiner JF; Adams AS; Dyer W; Beals J; Henderson WG; Desai J; Morales LS; Nichols GA; Lawrence JM; Waitzfelder B; Butler MG; Pathak RD; Hamman RF; Manson SM
BMJ Open Diabetes Res Care; 2014; 2(1):e000043. PubMed ID: 25452877
[TBL] [Abstract][Full Text] [Related]
8. Interpreting adverse signals in diabetes drug development programs.
Bailey CJ
Diabetes Care; 2013 Jul; 36(7):2098-106. PubMed ID: 23695817
[TBL] [Abstract][Full Text] [Related]
9. Insulin enhances the effect of nitric oxide at inhibiting neointimal hyperplasia in a rat model of type 1 diabetes.
Varu VN; Ahanchi SS; Hogg ME; Bhikhapurwala HA; Chen A; Popowich DA; Vavra AK; Martinez J; Jiang Q; Saavedra JE; Hrabie JA; Keefer LK; Kibbe MR
Am J Physiol Heart Circ Physiol; 2010 Sep; 299(3):H772-9. PubMed ID: 20562340
[TBL] [Abstract][Full Text] [Related]
10. Optimisation of the management of patients with coronary heart disease and type 2 diabetes mellitus.
Wilson SH; Kennedy FP; Garratt KN
Drugs Aging; 2001; 18(5):325-33. PubMed ID: 11392441
[TBL] [Abstract][Full Text] [Related]
11. Optimising therapy for insulin-treated type 2 diabetes mellitus.
Hermann LS
Drugs Aging; 2000 Oct; 17(4):283-94. PubMed ID: 11087006
[TBL] [Abstract][Full Text] [Related]
12. A rational approach to drug therapy of type 2 diabetes mellitus.
Chehade JM; Mooradian AD
Drugs; 2000 Jul; 60(1):95-113. PubMed ID: 10929931
[TBL] [Abstract][Full Text] [Related]
13. Effect of insulin therapy on macrovascular risk factors in type 2 diabetes.
Boyne MS; Saudek CD
Diabetes Care; 1999 Apr; 22 Suppl 3():C45-53. PubMed ID: 10189562
[TBL] [Abstract][Full Text] [Related]
14. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
Caballero AE
J Diabetes Complications; 2009; 23(2):143-52. PubMed ID: 18413192
[TBL] [Abstract][Full Text] [Related]
15. Improving macrovascular outcomes in type 2 diabetes: Outcome studies in cardiovascular risk and metabolic control.
Schneider CA
Curr Med Res Opin; 2006; 22 Suppl 2():S15-26. PubMed ID: 16914072
[TBL] [Abstract][Full Text] [Related]
16. Impact of glycemic treatment choices on cardiovascular complications in type 2 diabetes.
Weiss IA; Valiquette G; Schwarcz MD
Cardiol Rev; 2009; 17(4):165-75. PubMed ID: 19525678
[TBL] [Abstract][Full Text] [Related]
17. Effects of oral antihyperglycemic agents in modifying macrovascular risk factors in type 2 diabetes.
Lebovitz HE
Diabetes Care; 1999 Apr; 22 Suppl 3():C41-4. PubMed ID: 10189561
[TBL] [Abstract][Full Text] [Related]
18. Prevention of coronary heart disease in type 2 diabetes.
Mykkänen L
Int J Clin Pract Suppl; 2000 Oct; (113):40-5. PubMed ID: 11965831
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
